Magnus Financial Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Magnus Financial Group’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$2.47K	–	410
2026 Q1	$2.47K	Hold	10,000	–	–	﹤0.01%	373
2025 Q4	$4.2K	Hold	10,000	–	–	﹤0.01%	418
2025 Q3	$6.73K	Hold	10,000	–	–	﹤0.01%	402
2025 Q2	$5.41K	Hold	10,000	–	–	﹤0.01%	381
2025 Q1	$6.56K	Hold	10,000	–	–	﹤0.01%	365
2024 Q4	$10.2K	Hold	10,000	–	–	﹤0.01%	363
2024 Q3	$8.66K	Buy	+10,000	New	+$7.33K	﹤0.01%	340

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Magnus Financial Group's SGMO Position: Q2 2026 in Review

Magnus Financial Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 10,000 shares — an estimated $2.47K sold.

Magnus Financial Group first reported a position in SGMO in Q3 2024 and held it in 7 quarters. The position peaked at $10.2K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Magnus Financial Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Magnus Financial Group sold 10,000 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $2.47K.
Magnus Financial Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2024 and held it in 7 quarters.
Magnus Financial Group's SANGAMO THERAPEUTICS INC position peaked at $10.2K in Q4 2024.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Magnus Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.